Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

Phase 2

1(50.0%)

N/A

1(50.0%)

2Total

Phase 2(1)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT04369209Recruiting

A Registered Cohort Study on FSHD1

Role: lead

NCT04010214Recruiting

A Registered Cohort Study on Cerebellar Ataxia in the Organization in South-East China for Cerebellar Ataxia Research (OSCCAR)

Role: lead

NCT05502432Not ApplicableCompleted

Repetitive Transcranial Magnetic Stimulation in SCA3 Patients

Role: lead

NCT04629872Phase 2Unknown

Fingolimod in Endovascular Treatment of Ischemic Stroke

Role: lead

NCT04303962Unknown

Efficacy of Intravenous Gamma Globulin on Guillain-Barre Syndrome

Role: lead

NCT04010188Recruiting

A Registered Cohort Study on Charcot-Marie-Tooth Disease

Role: lead

NCT04637074Unknown

A Cohort Study on Thrombectomy for Stroke

Role: lead

NCT04012671Recruiting

A Registered Cohort Study on Duchenne Muscular Dystrophy

Role: lead

NCT04386018Unknown

A Registered Cohort Study of Inflammatory Demyelination Disease

Role: lead

All 9 trials loaded